Working...
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT02147990
Brief Title: TIGER-2: A Phase 2, Open-label, Multicenter, Safety and Efficacy Study of Oral CO-1686 as 2nd Line EGFR-directed TKI in Patients With Mutant EGFR Non-small Cell Lung Cancer (NSCLC)

First Submitted : May 13, 2014
First Submitted that Met QC Criteria : May 23, 2014
First Posted : May 28, 2014 (Estimate)

Last Update Submitted that Met QC Criteria : September 7, 2018
Last Update Posted : September 11, 2018